Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06439368

Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery

Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery: a Randomized, Double-blind, Parallel-controlled, Multicenter Clinical Study

Sponsor: Nanfang Hospital, Southern Medical University

Conditions Postoperative Pain Rehabilitation

Interventions Dezocine

Updated 2 times since 2024 Last updated: May 27, 2024 Started: Jan 5, 2023 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Postoperative Pain and Rehabilitation and is currently actively recruiting participants. Nanfang Hospital, Southern Medical University leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanfang Hospital, Southern Medical University
Yangtze River Pharmaceutical Group Co., Ltd.

Data source: Yangtze River Pharmaceutical Group Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China